MedPath

Potassium

Generic Name
Potassium
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
K
CAS Number
7440-09-7
Unique Ingredient Identifier
RWP5GA015D
Background

Potassium is an essential nutrient, like Calcium and Magnesium. It was identified as a shortfall nutrient by the 2015-2020 Advisory Committee of Dietary Guidelines for Americans. Many conditions and diseases interfere with normal body potassium balance, and underconsumption of potassium is one example. Hypokalemia (low potassium) or hyperkalemia (high potassium) may result, manifesting as various signs and symptoms. Some examples of potassium-related complications include life-threatening arrhythmia, neuromuscular dysfunction, diarrhea, nausea, and vomiting.

Various pharmacological preparations have been formulated to replenish potassium. They are available in an assortment of tablet, injection, and other forms, depending on the setting and condition being treated. Potassium is often a key ingredient for intravenous fluids, given to patients in clinical settings for rehydration, nutrition, and replenishment of electrolytes. Examples of potassium formulations include potassium citrate, potassium chloride, and potassium with dextrose and sodium chloride.

Indication

General uses of potassium

Potassium is indicated to treat a variety of conditions. Firstly, it used to replenish potassium that has been depleted by conditions including but not limited to malabsorption, decreased intake, or excess sodium intake. The causes of potassium deficiency are numerous. The following indications for potassium are not comprehensive, but include the main indications for which this nutrient is used. Various products and preparations contain potassium.

Potassium chloride

Potassium chloride is one of the main preparations of potassium used in a clinical setting. The oral solution is indicated for the prevention and treatment of hypokalemia presenting with or without metabolic alkalosis, in patients who have failed conservative management with potassium-rich foods or diuretic dose titrations. The injection form of potassium chloride is indicated to replenish potassium in patients who are not feasible candidates for oral potassium. Highly concentrated potassium is intended for the treatment of potassium deficiency in fluid restricted individuals who cannot tolerate fluid volumes normally associated with injected potassium solutions that contain lower concentrations.

Finally, the extended-release tablet preparation of potassium chloride is used to treat hypokalemia with or without metabolic alkalosis, to treat digitalis intoxication, and to manage patients with hypokalemic familial periodic paralysis. It is also used in the prevention of hypokalemia in those who are at a high risk of negative clinical outcomes if hypokalemia occurs; patients on digitalis or those with cardiac arrhythmias would be at particular risk of negative outcomes.

Potassium chloride with dextrose and sodium chloride

This liquid preparation is is indicated in a clinical setting as a source of water, calories and electrolytes. Potassium acetate solution is meant as an alternative to potassium chloride, replenishing potassium and added to large volume infusion fluids for intravenous injection.

Potassium citrate

The potassium citrate preparation is used for the management of renal tubular acidosis (RTA) with calcium stones (nephrolithiasis); calcium oxalate stones by any cause, and uric acid nephrolithiasis (with or without calcium stones). This regimen also includes adequate water intake (leading to a urine out put of 2 L/day or more) and sodium restriction.

Associated Conditions
Caloric Intake, Electrolyte and fluid balance conditions, Hydration, Hypokalemia, Potassium
Associated Therapies
-

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis

Phase 4
Active, not recruiting
Conditions
Sinus Infection
Acute Sinusitis
Interventions
First Posted Date
2023-10-10
Last Posted Date
2025-01-10
Lead Sponsor
Daniel Merenstein
Target Recruit Count
3720
Registration Number
NCT06076304
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

🇺🇸

MedStar Health Research Institute, Hyattsville, Maryland, United States

and more 4 locations

Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism

Phase 2
Completed
Conditions
Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment
Interventions
First Posted Date
2016-07-07
Last Posted Date
2021-06-28
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
16
Registration Number
NCT02824718
Locations
🇫🇷

AP-HP Hopital Europeen Georges Pompidou, Paris, France

Antibiotic Therapy Versus Appendectomy for Acute Appendicitis

Not Applicable
Completed
Conditions
Appendicitis
Interventions
First Posted Date
2005-08-26
Last Posted Date
2009-02-12
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
243
Registration Number
NCT00135603
Locations
🇫🇷

Lariboisière Hospital, Department of Digestive Surgery, Paris, France

🇫🇷

Antoine Béclère Hospital - Department of Surgery, Clamart, France

🇫🇷

Henri Mondor Hospital, Creteil, France

and more 2 locations

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

Not Applicable
Completed
Conditions
Neurosyphilis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
100
Registration Number
NCT00000648
Locations
🇺🇸

Northwestern Univ Med School, Chicago, Illinois, United States

🇺🇸

Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

🇺🇸

Beth Israel Deaconess Med Ctr, Boston, Massachusetts, United States

and more 39 locations
© Copyright 2025. All Rights Reserved by MedPath